Safety and efficacy of pazopanib in heavily pretreated and treatment-naive patients with metastatic renal cell carcinoma (mRCC): A single center experience of the Medical University of Vienna, Austria.

被引：0
|
作者：
Schmidinger, Manuela
Bojic, Marija
Vogl, Ursula Maria
Klingler, Christoph
Kramer, Gero
Zielinski, Christoph
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[3] Med Univ Vienna, Ctr Canc, Vienna, Austria
[4] Dept Med 1, Div Oncol, Vienna, Austria
[5] Dept Urol, Vienna, Austria
[6] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15090
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of apatinib monotherapy in metastatic renal cell carcinoma (mRCC) patients: A single-arm observational study
    Cui, Yan
    Cao, Yuxuan
    Cao, Muyang
    Chen, Xueting
    Liu, Guobin
    Chen, Hui
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 936.e1 - 936.e6
  • [22] Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients
    Barth, Claire
    Naveau, Louise
    Touboul, Emmanuel
    Perie, Sophie
    Bamogho, Edith
    Haberer-Guillerm, Sophie
    Schlienger, Michel
    St Guily, Jean Lacau
    Huguet, Florence
    ANTI-CANCER DRUGS, 2016, 27 (04) : 349 - 352
  • [23] A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC)
    Sternberg, C. N.
    Szczylik, C.
    Lee, E.
    Salman, P. V.
    Mardiak, J.
    Davis, I. D.
    Pandite, L.
    Chen, M.
    McCann, L.
    Hawkins, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] A randomized double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment-naive locally advanced or metastatic renal cell carcinoma (mRCC)
    Escudier, B. J.
    Cella, D.
    Gschwend, J. E.
    Powles, T.
    Sternberg, C. N.
    Hodge, R.
    Lau, M.
    Neary, M.
    Mehmud, F.
    Eisen, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Renal safety of sunitinib treatment: A prospective study for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Rixe, O.
    Meric, J. B.
    Alexandre, J.
    Goldwasser, F.
    Izzedine, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 36 - 36
  • [26] Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience
    Abd Ghafar, Nahjatul Kursyiah
    Alip, Adlinda
    Ong, Teng Aik
    Yap, Ning Yi
    Saad, Marniza
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1303 - 1311
  • [27] The impact of kidney function on the efficacy and safety of pazopanib in metastatic renal cell carcinoma (mRCC) patients: CORE-UR0-01 study.
    Vitale, Maria Giuseppa
    Masini, Cristina
    Procopio, Giuseppe
    De Giorgi, Ugo
    Buti, Sebastiano
    Rossetti, Sabrina
    Iacovelli, Roberto
    Mucciarini, Claudia
    Cosmai, Laura
    Vignani, Francesca
    Prati, Giuseppe
    Scagliarini, Sarah
    Berselli, Annalisa
    Pinto, Carmine
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Treatment-associated liver-toxicity in patients with advanced metastatic renal cell carcinoma (mRCC) treated with Pazopanib
    Rickmann, M.
    Seidel, C.
    Reuter, C.
    Trummer, A.
    Ganser, A.
    Gruenwald, V
    ONKOLOGIE, 2013, 36 : 76 - 77
  • [29] A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).
    Hutson, T. E.
    Bukowski, R. M.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M. G.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K. D.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Smoking habit and its impact on the efficacy and safety of sunitinib in metastatic renal cell carcinoma (mRCC) patients
    Ruiz, A. L.
    Suarez, B.
    Llinares, J.
    Esteban, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S656 - S657
12345